The board of directors of Pfizer Inc (NYSE:PFE) declared on Thursday its dividend of USD0.34 on its common stock for the Q4 2018.
Shareholders of record at the close of business on 9 November 2018 will receive the dividend payment on 3 December 2018.
In addition, the cash dividend will be the company's 320th consecutive quarterly dividend.
According to the company, it is engaged in the discovery, development and manufacture of health care products, including medicines and vaccines as well as many of the world's best-known consumer health care products.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government